Literature DB >> 12176024

Platelet-derived growth factor-B and -C and active alpha-receptors in medulloblastoma cells.

Johanna Andrae1, Catrin Molander, Anja Smits, Keiko Funa, Monica Nistér.   

Abstract

The malignant childhood brain tumor medulloblastoma belongs to the group of primitive neuroectodermal tumours (PNETs). Medulloblastomas are thought to arise from remnants of the transient external germinal layer in the cerebellum. Proliferation, differentiation, and motility of cells in the central nervous system are regulated by growth factors, e.g., platelet-derived growth factor (PDGF). Recently, it was shown that higher level of PDGF alpha-receptor expression is characteristic of metastatic medulloblastomas. We have investigated five medulloblastoma/PNET cell lines and found that the PDGF alpha-receptor is actively signalling in most of them, an activity most likely driven by endogenously produced PDGF-C. PDGF-C is normally present in cells of the developing external germinal layer and our results are consistent with the idea that medulloblastomas are derived from such cells undergoing early neuronal differentiation. Moreover, the expression of PDGF and its receptors was associated with neuronal characteristics, but not with high levels of c-myc expression in the medullablastoma cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12176024     DOI: 10.1016/s0006-291x(02)00917-8

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

1.  Preclinical testing of tandutinib in a transgenic medulloblastoma mouse model.

Authors:  Sachiko Ohshima-Hosoyama; Monika A Davare; Suresh I Prajapati; Jinu Abraham; Sangeet Lal; Laura D Nelon; Aoife Kilcoyne; Francis J Giles; Martha A Hanes; Brian P Rubin; Charles Keller
Journal:  J Pediatr Hematol Oncol       Date:  2012-03       Impact factor: 1.289

2.  Platelet-derived growth factor-C (PDGF-C) activation by serine proteases: implications for breast cancer progression.

Authors:  Newton J Hurst; Abdo J Najy; Carolyn V Ustach; Lisa Movilla; Hyeong-Reh Choi Kim
Journal:  Biochem J       Date:  2012-02-01       Impact factor: 3.857

3.  A PDGFRA promoter polymorphism, which disrupts the binding of ZNF148, is associated with primitive neuroectodermal tumours and ependymomas.

Authors:  C De Bustos; A Smits; B Strömberg; V P Collins; M Nistér; G Afink
Journal:  J Med Genet       Date:  2005-01       Impact factor: 6.318

4.  Amplification and overexpression of KIT, PDGFRA, and VEGFR2 in medulloblastomas and primitive neuroectodermal tumors.

Authors:  Tea Blom; Annariikka Roselli; Valtteri Häyry; Olli Tynninen; Kirmo Wartiovaara; Miikka Korja; Kristiina Nordfors; Hannu Haapasalo; Nina N Nupponen
Journal:  J Neurooncol       Date:  2009-09-25       Impact factor: 4.130

5.  An oncogenic activity of PDGF-C and its splice variant in human breast cancer.

Authors:  Alyssa Bottrell; Yong Hong Meng; Abdo J Najy; Newton Hurst; Seongho Kim; Chong Jai Kim; Eun-Sook Kim; Aree Moon; Eun Joo Kim; So Yeon Park; Hyeong-Reh Choi Kim
Journal:  Growth Factors       Date:  2019-09-23       Impact factor: 2.511

6.  Differentiation in neuroblastoma: diffusion-limited hypoxia induces neuro-endocrine secretory protein 55 and other markers of a chromaffin phenotype.

Authors:  Fredrik Hedborg; Reiner Fischer-Colbrie; Nurtena Ostlin; Bengt Sandstedt; Maxine G B Tran; Patrick H Maxwell
Journal:  PLoS One       Date:  2010-09-17       Impact factor: 3.240

7.  Platelet-derived growth factor-C (PDGF-C) induces anti-apoptotic effects on macrophages through Akt and Bad phosphorylation.

Authors:  Dain Son; Yi Rang Na; Eung-Soo Hwang; Seung Hyeok Seok
Journal:  J Biol Chem       Date:  2014-01-13       Impact factor: 5.157

8.  Tissue plasminogen activator is a potent activator of PDGF-CC.

Authors:  Linda Fredriksson; Hong Li; Christina Fieber; Xuri Li; Ulf Eriksson
Journal:  EMBO J       Date:  2004-09-16       Impact factor: 11.598

9.  Novel agents targeting the IGF-1R/PI3K pathway impair cell proliferation and survival in subsets of medulloblastoma and neuroblastoma.

Authors:  Anna Wojtalla; Fabiana Salm; Ditte G Christiansen; Tiziana Cremona; Paulina Cwiek; Tarek Shalaby; Nicole Gross; Michael A Grotzer; Alexandre Arcaro
Journal:  PLoS One       Date:  2012-10-08       Impact factor: 3.240

Review 10.  Molecularly targeted therapy for pediatric brain tumors.

Authors:  Warren K E
Journal:  J Neurooncol       Date:  2005-12       Impact factor: 4.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.